Results 261 to 270 of about 400,814 (315)
Rheumatoid Arthritis Diagnostic and Monitoring Testing Patterns by Physicians and Advanced Practice Providers in the United States, 2012 to 2024. [PDF]
ACR Open RheumatolLee MK, Lee K, Alfego D, Naides SJ.
europepmc +1 more source
Clinical Images: Subcutaneous panniculitis‐like T cell lymphoma
Arthritis &Rheumatology, EarlyView.
S Chambers, CN Myrdal, VP Werth
wiley +1 more source
The challenges and opportunities for equitable global access to medications for paediatric rheumatology in low-to middle-income countries: a review on behalf of the Paediatric Global Task Force for Musculoskeletal Health. [PDF]
Arthritis Res TherScott C +12 more
europepmc +1 more source
Single-center experience of voclosporin use for pediatric lupus nephritis: a case series. [PDF]
Rheumatology (Oxford)Hazan R +3 more
europepmc +1 more source
Bringing back 'significance' to MGUS. [PDF]
Rheumatology (Oxford)Kouranloo K +7 more
europepmc +1 more source
Dosing Biologic Drugs for Patients With Obesity: One Size Does Not Fit All
Arthritis &Rheumatology, EarlyView.
Stephen J. Balevic +2 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
JAMA: The Journal of the American Medical Association, 1995
In some populations, the presence and the dose of the "rheumatoid" epitope have been associated with severe rheumatoid arthritis. Newer treatments include oral antibiotics, oral type II collagen, and a number of biological products. Identification of a mutation in the type II procollagen genes is evidence that some clinical osteoarthritis is ...
G S, Alarcón, K V, Straaton
openaire +2 more sources
In some populations, the presence and the dose of the "rheumatoid" epitope have been associated with severe rheumatoid arthritis. Newer treatments include oral antibiotics, oral type II collagen, and a number of biological products. Identification of a mutation in the type II procollagen genes is evidence that some clinical osteoarthritis is ...
G S, Alarcón, K V, Straaton
openaire +2 more sources
Rheumatology International, 2020
Malaysia is a developing country in the South-East Asian region with a significant burden of disability from musculoskeletal disease. Rheumatology in Malaysia is a relatively young speciality. Currently, there is approximately 1 rheumatologist per 390,000 population, mostly concentrated in the urban areas.
Swan Sim Yeap +3 more
openaire +2 more sources
Malaysia is a developing country in the South-East Asian region with a significant burden of disability from musculoskeletal disease. Rheumatology in Malaysia is a relatively young speciality. Currently, there is approximately 1 rheumatologist per 390,000 population, mostly concentrated in the urban areas.
Swan Sim Yeap +3 more
openaire +2 more sources